Engineering cellular resistance to HIV

N Engl J Med. 2014 Mar 6;370(10):968-9. doi: 10.1056/NEJMe1400593.

Authors

Mark A Kay¹, Bruce D Walker

Affiliation

¹ From the Departments of Pediatrics and Genetics, Stanford University School of Medicine, Stanford, CA (M.A.K.); and the Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA (B.D.W.).

PMID: 24597871
DOI: 10.1056/NEJMe1400593

No abstract available

Publication types

Editorial
Comment

MeSH terms

CD4-Positive T-Lymphocytes / transplantation*
Female
Genetic Therapy*
HIV Infections / therapy*
Humans
Lymphocyte Transfusion*
Male
Receptors, CCR5 / genetics*

Substances

CCR5 protein, human
Receptors, CCR5